Pathstone Holdings, LLC Guardant Health, Inc. Transaction History
Pathstone Holdings, LLC
- $25.3 Billion
- Q2 2025
A detailed history of Pathstone Holdings, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 24,716 shares of GH stock, worth $2.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,716
Previous 7,597
225.34%
Holding current value
$2.3 Million
Previous $323,000
298.14%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GH
# of Institutions
425Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$1.13 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.05 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$477 Million0.25% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$463 Million0.05% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$395 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.51B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...